Logo image of KDA.CA

KDA GROUP INC (KDA.CA) Stock Fundamental Analysis

TSX-V:KDA - CA48669F1071 - Common Stock

0.27 CAD
0 (0%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, KDA scores 1 out of 10 in our fundamental rating. KDA was compared to 9 industry peers in the Health Care Technology industry. KDA has a bad profitability rating. Also its financial health evaluation is rather negative. KDA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

KDA had negative earnings in the past year.
KDA had a negative operating cash flow in the past year.
In multiple years KDA reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: KDA reported negative operating cash flow in multiple years.
KDA.CA Yearly Net Income VS EBIT VS OCF VS FCFKDA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

KDA's Return On Assets of -71.35% is in line compared to the rest of the industry. KDA outperforms 44.44% of its industry peers.
KDA's Return On Equity of -73.64% is in line compared to the rest of the industry. KDA outperforms 55.56% of its industry peers.
Industry RankSector Rank
ROA -71.35%
ROE -73.64%
ROIC N/A
ROA(3y)2.11%
ROA(5y)-2.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KDA.CA Yearly ROA, ROE, ROICKDA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for KDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KDA.CA Yearly Profit, Operating, Gross MarginsKDA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K

More info and screens

3

2. Health

2.1 Basic Checks

KDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KDA has been increased compared to 1 year ago.
KDA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, KDA has an improved debt to assets ratio.
KDA.CA Yearly Shares OutstandingKDA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
KDA.CA Yearly Total Debt VS Total AssetsKDA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

KDA has an Altman-Z score of 82.35. This indicates that KDA is financially healthy and has little risk of bankruptcy at the moment.
KDA has a better Altman-Z score (82.35) than 100.00% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that KDA is not too dependend on debt financing.
KDA's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. KDA outperforms 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 82.35
ROIC/WACCN/A
WACC9.12%
KDA.CA Yearly LT Debt VS Equity VS FCFKDA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

KDA has a Current Ratio of 0.60. This is a bad value and indicates that KDA is not financially healthy enough and could expect problems in meeting its short term obligations.
KDA has a Current ratio (0.60) which is in line with its industry peers.
A Quick Ratio of 0.60 indicates that KDA may have some problems paying its short term obligations.
KDA has a Quick ratio of 0.60. This is comparable to the rest of the industry: KDA outperforms 44.44% of its industry peers.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.6
KDA.CA Yearly Current Assets VS Current LiabilitesKDA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

KDA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -168.85%.
Looking at the last year, KDA shows a very negative growth in Revenue. The Revenue has decreased by -33.71% in the last year.
The Revenue for KDA have been decreasing by -63.61% on average. This is quite bad
EPS 1Y (TTM)-168.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.83%
Revenue 1Y (TTM)-33.71%
Revenue growth 3Y-81.78%
Revenue growth 5Y-63.61%
Sales Q2Q%-27.93%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KDA.CA Yearly Revenue VS EstimatesKDA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KDA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KDA.CA Price Earnings VS Forward Price EarningsKDA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KDA.CA Per share dataKDA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KDA GROUP INC

TSX-V:KDA (9/5/2025, 7:00:00 PM)

0.27

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)06-27 2025-06-27
Earnings (Next)11-20 2025-11-20
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.76%
Ins Owner ChangeN/A
Market Cap52.45M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 373.82
P/FCF N/A
P/OCF N/A
P/B 4.69
P/tB 91.4
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.06
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -71.35%
ROE -73.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.11%
ROA(5y)-2.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 49.55%
Cap/Sales 1400.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.6
Altman-Z 82.35
F-Score3
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)390.7%
Cap/Depr(5y)342.37%
Cap/Sales(3y)1339.12%
Cap/Sales(5y)805.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-168.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.71%
Revenue growth 3Y-81.78%
Revenue growth 5Y-63.61%
Sales Q2Q%-27.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-54.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-956.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-131.41%
OCF growth 3YN/A
OCF growth 5YN/A